<p><strong>过去两年半</strong>，由所谓的 “七大巨头” 引领的人工智能热潮为这些股票的投资者带来了显著的回报。然而，这些令人振奋的日子似乎已经结束，至少目前是这样。在经历了一场残酷的抛售后，标准普尔 500 指数和纳斯达克指数一度跌入或接近熊市区域，但这两个指数随后恢复了损失，交易接近历史最高点。投资者现在面临着为今年剩余时间及未来选择正确路径的挑战。投资的分岔路口仍然存在许多担忧，包括关税、2025 年衰退的潜在可能性以及地缘政治问题。</p>
<ul>
<li>在经历了一段波动后，国债市场的收益率已经稳定。</li>
</ul>
<ul>
<li>对债券和股票市场波动性的担忧使投资者转向优质的分红股票。</li>
</ul>
<ul>
<li>高盛的信念名单包含了华尔街领先公司的顶级股票推荐。</li>
</ul>
<ul>
<li>信念名单中的分红股票对你来说是个好主意吗？为什么不安排一次与附近的财务顾问会面，审查你的投资组合呢？点击这里开始今天的旅程。（赞助）</li>
</ul>
<p><strong>我们决定</strong> 筛选当前高盛美国信念名单中的股票，这些股票具有可靠的总回报潜力，并为寻求被动收入的人提供稳定的分红。三家顶级公司引起了我们的注意，它们提供可靠的、在某些情况下是可观的分红，并且相对于高盛的目标价格具有巨大的上行潜力。当它们成为全球最负盛名的投资银行的顶级股票推荐时，它们很可能会引起精明投资者的关注。</p>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<h2><strong>我们为什么</strong> 推荐高盛股票</h2>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2018/04/goldman-sachs.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2018/04/goldman-sachs.jpg"/></p>
<p><strong>高盛</strong> 是华尔街及全球投资领域公认的领导者。该公司的顶尖研究部门继续为客户提供投资领域内最佳的想法，并可能在未来几年内继续这样做。</p>
<h2><strong>百特国际</strong></h2>
<p><strong>这家医疗</strong> 巨头为 2025 年提供了稳定的分红和出色的增长潜力。百特国际公司（NYSE: BAX）在美国提供一系列医疗产品。它通过三个部门运营：</p>
<ul>
<li>医疗产品和疗法</li>
<li>医疗系统和技术</li>
<li>制药</li>
</ul>
<p><strong>该公司</strong> 提供：</p>
<ul>
<li>无菌静脉（IV）溶液</li>
<li>输液系统和设备</li>
<li>肠外营养疗法</li>
<li>管理套件</li>
<li>仿制注射药物</li>
<li>外科止血和密封产品</li>
<li>先进的外科设备</li>
<li>智能床系统</li>
<li>患者监测和诊断技术</li>
<li>呼吸健康设备</li>
<li>先进的外科空间设备，包括手术室集成技术</li>
<li>精密定位设备及其他配件。</li>
</ul>
<p><strong>百特还</strong> 提供特殊注射药物、吸入麻醉剂和处方药的配制服务。</p>
<p><strong>其产品</strong> 用于：</p>
<ul>
<li>医院</li>
<li>护理院</li>
<li>康复中心</li>
<li>门诊手术中心</li>
<li>医生办公室</li>
<li>肾透析中心</li>
<li>在医生监督下的家庭患者</li>
</ul>
<p><strong>该公司</strong> 通过直销团队、独立分销商、药品批发商、特殊药房或其他替代地点提供其产品。</p>
<p><strong>它与</strong>Celerity Pharmaceuticals 达成协议，开发用于急救的仿制注射预混合和肿瘤溶解产品。该公司在东欧、中东、非洲、拉丁美洲、亚洲、西欧、加拿大、日本、澳大利亚和新西兰运营。</p>
<p><strong>高盛</strong> 的目标价格为 39 美元。达到该目标将实现 23% 的收益。</p>
<h2>科迪亚克天然气服务</h2>
<p><strong>随着天然</strong> 气需求大增，这是一个稳健的能源投资选择。科迪亚克天然气服务公司（NYSE: KGS）是美国的一家合同压缩服务提供商，作为生产和运输天然气及石油的基础设施中的一个环节。</p>
<p><strong>该公司的</strong> 合同服务部门包括运营公司自有和客户自有的压缩、气体处理和冷却基础设施，支持天然气和石油的生产、收集、加工和运输。</p>
<p><strong>其其他服务</strong> 部门包括广泛的服务，以支持客户的需求，包括：</p>
<ul>
<li>站点建设</li>
<li>客户自有压缩设备的维护和检修</li>
<li>运费和起重机费用</li>
<li>零件销售及其他附属的时间和材料基础服务</li>
</ul>
<p><strong>该公司</strong> 向高容量天然气收集系统、加工设施、多井气举升应用和天然气传输系统的石油和天然气生产商及中游客户提供服务。</p>
<p><strong>达到</strong> 高盛的 44 美元目标价格将实现 24% 的收益。</p>
<h2><strong>Viper Energy</strong></h2>
<p><strong>Viper Energy</strong> 公司（NASDAQ: VNOM）拥有并收购位于二叠纪盆地的石油和天然气资产的矿产和特许权利益。凭借引人注目的分红，这家中型能源公司相对于高盛的目标价格具有巨大的上行潜力。Viper Energy 是一家独立的石油和天然气公司，专注于收购、开发、勘探和开采非常规的陆上石油和天然气储备。</p>
<p><strong>该公司</strong> 在北美拥有、收购和开发石油和天然气资产。公司的资产包括位于德克萨斯州西部的二叠纪盆地的石油和天然气资产的矿产和特许权利益，几乎全部租赁给承担运营和开发成本的工作权益所有者。</p>
<p><strong>其资产</strong> 包括 987,861 英亩的总面积和 35,671 英亩的净特许权利益，主要位于二叠纪盆地。</p>
<p><strong>Viper Energy</strong> 在德克萨斯州霍华德县的矿产和特许权利益包括大约 1,691 英亩的净特许权土地，位于二叠纪盆地，平均净特许权利益约为 8.6%。</p>
<p><strong>高盛</strong> 的目标价为 72 美元，较当前水平有惊人的 73% 的上涨空间。</p>
<p>高盛看好四只抗衰退的高收益公用事业股息股票</p>
<p>关于高盛三大股息股票推荐的文章显示其潜在上涨空间可达 73%，首发于 24/7 Wall St..</p>

VNOM

<p>高盛从其美国信念名单中识别出三只顶级股息股票，潜在上涨幅度可达 73%。这些股票对寻求在市场波动中获得被动收入的投资者具有吸引力。所选公司包括 Baxter International、Kodiak Gas Services 和 Viper Energy，每家公司都具有稳健的增长前景和可靠的股息。Baxter 以其医疗保健产品而闻名，Kodiak 以其天然气服务而著称，Viper 则因其在石油和天然气领域的矿产和特许权利益而受到关注。高盛预计每只股票都将实现显著的价格增长，使其成为有吸引力的投资选择</p>

<p><strong>The artificial</strong> intelligence rally over the past two and a half years, led by the so-called Magnificent 7, delivered remarkable returns for investors in those stocks. However, those heady days appear to be over, at least for now. After a brutal sell-off that briefly pushed the S&amp;P 500 and the Nasdaq into or close to bear market territory, both indexes have since recovered their losses and are trading close to all-time highs again. Investors are now faced with the challenge of picking the right path for the rest of the year and beyond. The fork in the road of investing still presents numerous concerns, including tariffs, the potential for a 2025 recession, and geopolitical concerns.</p>
<div class="lb-trans"><p><strong>过去两年半</strong>，由所谓的 “七大巨头” 引领的人工智能热潮为这些股票的投资者带来了显著的回报。然而，这些令人振奋的日子似乎已经结束，至少目前是这样。在经历了一场残酷的抛售后，标准普尔 500 指数和纳斯达克指数一度跌入或接近熊市区域，但这两个指数随后恢复了损失，交易接近历史最高点。投资者现在面临着为今年剩余时间及未来选择正确路径的挑战。投资的分岔路口仍然存在许多担忧，包括关税、2025 年衰退的潜在可能性以及地缘政治问题。</p>
</div><ul>
<li>After a volatile stretch, yields in the Treasury bond market have stabilized.</li>
</ul>
<div class="lb-trans"><ul>
<li>在经历了一段波动后，国债市场的收益率已经稳定。</li>
</ul>
</div><ul>
<li>Concerns about the volatility in the bond and stock markets are leading investors to top-quality dividend stocks.</li>
</ul>
<div class="lb-trans"><ul>
<li>对债券和股票市场波动性的担忧使投资者转向优质的分红股票。</li>
</ul>
</div><ul>
<li>The Goldman Sachs Conviction List contains the top stock picks at one of Wall Street’s leading firms.</li>
</ul>
<div class="lb-trans"><ul>
<li>高盛的信念名单包含了华尔街领先公司的顶级股票推荐。</li>
</ul>
</div><ul>
<li>Are the dividend stocks in the Conviction List a good idea for you? Why not schedule a meeting with a financial advisor near you to review your portfolio? Click here to get started today. (Sponsored)</li>
</ul>
<div class="lb-trans"><ul>
<li>信念名单中的分红股票对你来说是个好主意吗？为什么不安排一次与附近的财务顾问会面，审查你的投资组合呢？点击这里开始今天的旅程。（赞助）</li>
</ul>
</div><p><strong>We decided</strong> to screen the current Goldman Sachs U.S. Conviction List for stocks with solid total return potential that pay dependable dividends for those seeking passive income. Three top companies caught our attention, paying reliable, in some cases substantial, dividends with tremendous upside potential relative to the Goldman Sachs target prices. When they are among the top stock picks at the world’s most prestigious investment bank, they likely will catch the eye of savvy investors.</p>
<div class="lb-trans"><p><strong>我们决定</strong> 筛选当前高盛美国信念名单中的股票，这些股票具有可靠的总回报潜力，并为寻求被动收入的人提供稳定的分红。三家顶级公司引起了我们的注意，它们提供可靠的、在某些情况下是可观的分红，并且相对于高盛的目标价格具有巨大的上行潜力。当它们成为全球最负盛名的投资银行的顶级股票推荐时，它们很可能会引起精明投资者的关注。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<h2><strong>Why we</strong> recommend Goldman Sachs stocks</h2>
<div class="lb-trans"><h2><strong>我们为什么</strong> 推荐高盛股票</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2018/04/goldman-sachs.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2018/04/goldman-sachs.jpg"/></p>
<p><strong>Goldman Sachs</strong> is the acknowledged leader in the investment landscape on Wall Street and worldwide. The firm’s top-notch research department continues to provide clients with the best ideas across the investment spectrum and is likely to do so for years to come.</p>
<div class="lb-trans"><p><strong>高盛</strong> 是华尔街及全球投资领域公认的领导者。该公司的顶尖研究部门继续为客户提供投资领域内最佳的想法，并可能在未来几年内继续这样做。</p>
</div><h2><strong>Baxter International</strong></h2>
<div class="lb-trans"><h2><strong>百特国际</strong></h2>
</div><p><strong>This healthcare</strong> giant offers a solid dividend and outstanding growth potential for 2025. Baxter International Inc. (NYSE: BAX) provides a portfolio of healthcare products in the United States. It operates through three segments:</p>
<div class="lb-trans"><p><strong>这家医疗</strong> 巨头为 2025 年提供了稳定的分红和出色的增长潜力。百特国际公司（NYSE: BAX）在美国提供一系列医疗产品。它通过三个部门运营：</p>
</div><ul>
<li>Medical Products and Therapies</li>
<li>Healthcare Systems and Technologies</li>
<li>Pharmaceuticals</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗产品和疗法</li>
<li>医疗系统和技术</li>
<li>制药</li>
</ul>
</div><p><strong>The company</strong> offers:</p>
<div class="lb-trans"><p><strong>该公司</strong> 提供：</p>
</div><ul>
<li>Sterile intravenous (IV) solutions</li>
<li>Infusion systems and devices</li>
<li>Parenteral nutrition therapies</li>
<li>Administrative sets</li>
<li>Generic injectable pharmaceuticals</li>
<li>Surgical hemostat and sealant products</li>
<li>Advanced surgical equipment</li>
<li>Smart bed systems</li>
<li>Patient monitoring and diagnostic technologies</li>
<li>Respiratory health devices</li>
<li>Advanced equipment for the surgical space, comprising operating room integration technologies</li>
<li>Precision positioning devices and other accessories.</li>
</ul>
<div class="lb-trans"><ul>
<li>无菌静脉（IV）溶液</li>
<li>输液系统和设备</li>
<li>肠外营养疗法</li>
<li>管理套件</li>
<li>仿制注射药物</li>
<li>外科止血和密封产品</li>
<li>先进的外科设备</li>
<li>智能床系统</li>
<li>患者监测和诊断技术</li>
<li>呼吸健康设备</li>
<li>先进的外科空间设备，包括手术室集成技术</li>
<li>精密定位设备及其他配件。</li>
</ul>
</div><p><strong>Baxter also</strong> provides specialty injectable pharmaceuticals, inhaled anesthetics, and compounding services for prescription drugs.</p>
<div class="lb-trans"><p><strong>百特还</strong> 提供特殊注射药物、吸入麻醉剂和处方药的配制服务。</p>
</div><p><strong>Its products</strong> are used in:</p>
<div class="lb-trans"><p><strong>其产品</strong> 用于：</p>
</div><ul>
<li>Hospitals</li>
<li>Nursing homes</li>
<li>Rehabilitation centers</li>
<li>Ambulatory surgery centers</li>
<li>Doctors’ offices</li>
<li>Kidney dialysis centers</li>
<li>Patients at home under physician supervision</li>
</ul>
<div class="lb-trans"><ul>
<li>医院</li>
<li>护理院</li>
<li>康复中心</li>
<li>门诊手术中心</li>
<li>医生办公室</li>
<li>肾透析中心</li>
<li>在医生监督下的家庭患者</li>
</ul>
</div><p><strong>The company</strong> sells its products through a direct sales force, independent distributors, drug wholesalers, specialty pharmacies, or other alternate site providers.</p>
<div class="lb-trans"><p><strong>该公司</strong> 通过直销团队、独立分销商、药品批发商、特殊药房或其他替代地点提供其产品。</p>
</div><p><strong>It has an</strong> agreement with Celerity Pharmaceuticals to develop generic injectable premix and oncolytic products for acute care. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand.</p>
<div class="lb-trans"><p><strong>它与</strong>Celerity Pharmaceuticals 达成协议，开发用于急救的仿制注射预混合和肿瘤溶解产品。该公司在东欧、中东、非洲、拉丁美洲、亚洲、西欧、加拿大、日本、澳大利亚和新西兰运营。</p>
</div><p><strong>Goldman Sachs</strong> has a target price of $39. Achieving the target would result in a 23% gain.</p>
<div class="lb-trans"><p><strong>高盛</strong> 的目标价格为 39 美元。达到该目标将实现 23% 的收益。</p>
</div><h2>Kodiak Gas Services</h2>
<div class="lb-trans"><h2>科迪亚克天然气服务</h2>
</div><p><strong>With natural</strong> gas in big demand, this is a solid energy idea. Kodiak Gas Services Inc. (NYSE: KGS) is a contract compression service provider in the United States, serving as a link in the infrastructure that enables the production and transportation of natural gas and oil.</p>
<div class="lb-trans"><p><strong>随着天然</strong> 气需求大增，这是一个稳健的能源投资选择。科迪亚克天然气服务公司（NYSE: KGS）是美国的一家合同压缩服务提供商，作为生产和运输天然气及石油的基础设施中的一个环节。</p>
</div><p><strong>The company’s</strong> Contract Services segment comprises operating company-owned and customer-owned compression, gas treating, and cooling infrastructure, enabling the production, gathering, processing, and transportation of natural gas and oil.</p>
<div class="lb-trans"><p><strong>该公司的</strong> 合同服务部门包括运营公司自有和客户自有的压缩、气体处理和冷却基础设施，支持天然气和石油的生产、收集、加工和运输。</p>
</div><p><strong>Its Other Services</strong> segment consists of a broad range of services to support the needs of its customers, including:</p>
<div class="lb-trans"><p><strong>其其他服务</strong> 部门包括广泛的服务，以支持客户的需求，包括：</p>
</div><ul>
<li>Station construction</li>
<li>Customer-owned compression maintenance and overhaul</li>
<li>Freight and crane charges</li>
<li>Parts sales, and other ancillary time and material-based offerings</li>
</ul>
<div class="lb-trans"><ul>
<li>站点建设</li>
<li>客户自有压缩设备的维护和检修</li>
<li>运费和起重机费用</li>
<li>零件销售及其他附属的时间和材料基础服务</li>
</ul>
</div><p><strong>The company</strong> offers its services to oil and gas producers and midstream customers in high-volume gas gathering systems, processing facilities, multi-well gas lift applications, and natural gas transmission systems.</p>
<div class="lb-trans"><p><strong>该公司</strong> 向高容量天然气收集系统、加工设施、多井气举升应用和天然气传输系统的石油和天然气生产商及中游客户提供服务。</p>
</div><p><strong>Reaching the</strong> $44 Goldman Sachs price target would be a 24% gain.</p>
<div class="lb-trans"><p><strong>达到</strong> 高盛的 44 美元目标价格将实现 24% 的收益。</p>
</div><h2><strong>Viper Energy</strong></h2>
<div class="lb-trans"><h2><strong>Viper Energy</strong></h2>
</div><p><strong>Viper Energy</strong> Inc. (NASDAQ: VNOM) owns and acquires mineral and royalty interests in oil and natural gas properties in the Permian Basin. With an eye-popping dividend, this mid-cap energy play has tremendous upside to the Goldman Sachs target price. Viper Energy is an independent oil and natural gas company focused on the acquisition, development, exploration, and exploitation of unconventional, onshore oil and natural gas reserves.</p>
<div class="lb-trans"><p><strong>Viper Energy</strong> 公司（NASDAQ: VNOM）拥有并收购位于二叠纪盆地的石油和天然气资产的矿产和特许权利益。凭借引人注目的分红，这家中型能源公司相对于高盛的目标价格具有巨大的上行潜力。Viper Energy 是一家独立的石油和天然气公司，专注于收购、开发、勘探和开采非常规的陆上石油和天然气储备。</p>
</div><p><strong>The company</strong> owns, acquires, and exploits oil and natural gas properties in North America. The company’s assets consist of mineral and royalty interests in oil and natural gas properties, primarily located in the Permian Basin of West Texas, which are substantially all leased to working interest owners who bear the costs of operation and development.</p>
<div class="lb-trans"><p><strong>该公司</strong> 在北美拥有、收购和开发石油和天然气资产。公司的资产包括位于德克萨斯州西部的二叠纪盆地的石油和天然气资产的矿产和特许权利益，几乎全部租赁给承担运营和开发成本的工作权益所有者。</p>
</div><p><strong>Its assets</strong> consist of mineral interests and royalty interests underlying 987,861 gross acres and 35,671 net royalty acres primarily in the Permian Basin.</p>
<div class="lb-trans"><p><strong>其资产</strong> 包括 987,861 英亩的总面积和 35,671 英亩的净特许权利益，主要位于二叠纪盆地。</p>
</div><p><strong>Viper Energy’s</strong> mineral and royalty interests located in Howard County, Texas, include approximately 1,691 net royalty acres in the Permian Basin and have an average net royalty interest of roughly 8.6%.</p>
<div class="lb-trans"><p><strong>Viper Energy</strong> 在德克萨斯州霍华德县的矿产和特许权利益包括大约 1,691 英亩的净特许权土地，位于二叠纪盆地，平均净特许权利益约为 8.6%。</p>
</div><p><strong>The Goldman Sachs</strong> price target of $72 represents a stunning 73% gain from current levels.</p>
<div class="lb-trans"><p><strong>高盛</strong> 的目标价为 72 美元，较当前水平有惊人的 73% 的上涨空间。</p>
</div><p>Goldman Sachs Loves Four Recession-Proof High-Yield Utility Dividend Stocks</p>
<div class="lb-trans"><p>高盛看好四只抗衰退的高收益公用事业股息股票</p>
</div><p>The post 3 Top Goldman Sachs Dividend Stock Picks Have Up to 73% Upside Potential appeared first on 24/7 Wall St..</p>
<div class="lb-trans"><p>关于高盛三大股息股票推荐的文章显示其潜在上涨空间可达 73%，首发于 24/7 Wall St..</p>
</div>

高盛精选的三只股息股票有望上涨至多 73%